Savara (SVRA) Depreciation and Depletion (2016 - 2018)
Savara's (SVRA) quarterly Depreciation and Depletion came in at $139000.0 in Q4 2018, up 52.75% year-on-year from $91000.0 in Q4 2017, and up 9.45% on a QoQ basis from $127000.0 in Q3 2018.
Savara (SVRA) Depreciation and Depletion (2016 - 2018) Analysis & Trends
Savara (SVRA) has 3 years of Depreciation and Depletion data on file, last reported at $139000.0 in Q4 2018.
- On a quarterly basis, Depreciation and Depletion rose 52.75% year-over-year to $139000.0 in Q4 2018; TTM through Dec 2018 was $526000.0, a 44.9% increase from a year earlier, with the FY2021 full-year figure at $100000.0, down 66.67% from the prior year.
- Depreciation and Depletion for Q4 2018 stood at $139000.0, up from $127000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for SVRA reached as high as $153000.0 in Q2 2018 and fell as low as $85000.0 in Q2 2016.
- Historically, Depreciation and Depletion has averaged $104545.5 across 3 years, with a median of $91000.0 in 2017.
- Across the five-year window, Depreciation and Depletion gained 1.11% in 2017 and jumped 68.13% in 2018, its largest moves.
- Year by year, Depreciation and Depletion stood at $90000.0 in 2016, then gained by 1.11% to $91000.0 in 2017, then surged by 52.75% to $139000.0 in 2018.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $139000.0 in Q4 2018, $127000.0 in Q3 2018, and $153000.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | - |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 139,000.00 |
| Dec 31, 2018 | 139,000.00 |
| Sep 30, 2018 | 127,000.00 |
| Sep 30, 2018 | 127,000.00 |
| Jun 30, 2018 | 153,000.00 |
| Jun 30, 2018 | 153,000.00 |
| Mar 31, 2018 | 107,000.00 |
| Mar 31, 2018 | 107,000.00 |
| Dec 31, 2017 | 91,000.00 |
| Dec 31, 2017 | 91,000.00 |
| Sep 30, 2017 | 91,000.00 |
| Sep 30, 2017 | 91,000.00 |
| Jun 30, 2017 | 91,000.00 |
| Jun 30, 2017 | 91,000.00 |
| Mar 31, 2017 | 90,000.00 |
| Mar 31, 2017 | 90,000.00 |
| Dec 31, 2016 | 90,000.00 |
| Dec 31, 2016 | 90,000.00 |
| Sep 30, 2016 | 86,000.00 |
| Sep 30, 2016 | 86,000.00 |